Back to Search
JANICE DUTCHER, M.D.
M.D.
Specialist
NPI: 1730242124Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
1527481(NY)
Research & Publications (20)
Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies.
PMID 19229667·Med Oncol·2009
3-trial
Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group Study.
PMID 16222691·Cancer·2005
3-trial
Stratification by risk factors predicts survival on the active treatment arm in a randomized phase II study of interferon-gamma plus/minus interferon-alpha in advanced renal cell carcinoma (E6890).
PMID 14514977·Med Oncol·2003
3-trial
The role of Epstein-Barr virus and elevated levels of tumor necrosis factor in determining prognosis in Asian peripheral T-cell lymphomas.
PMID 12648503·Leuk Res·2003
8-other
High-dose interleukin-2 in metastatic disease: renal cell carcinoma and melanoma.
PMID 12469933·Oncology (Williston Park)·2002
8-other
Kidney cancer: the Cytokine Working Group experience (1986-2001): part II. Management of IL-2 toxicity and studies with other cytokines.
PMID 11917945·Med Oncol·2001
6-review
20th-century advances in drug therapy in oncology--Part. II.
PMID 11028247·J Clin Pharmacol·2000
6-review
Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.
PMID 10999727·Clin Cancer Res·2000
3-trial
Accelerated and blastic phase of chronic myeloid leukemia.
PMID 12057061·Curr Treat Options Oncol·2000
6-review
20th-century advances in drug therapy in oncology--Part I.
PMID 10975071·J Clin Pharmacol·2000
8-other
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993).
PMID 15621827·Leuk Lymphoma·2005
3-trial
In situ characterization of differences in the viscoelastic response of individual gram-negative and gram-positive bacterial cells.
PMID 19581369·J Bacteriol·2009
8-other
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
PMID 19652060·J Clin Oncol·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1000 10TH AVE, 11TH FLOOR
NEW YORK, NY 10019 - Phone
- (212) 523-2022
Quick Facts
- NPI
- 1730242124
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile